Valeo Pharma Inc CEO Steve Saviuk tells Proactive it has now secured public reimbursement coverage for its anticoagulant drugs Redesca and Redesca HP in nine Canadian provinces after striking a product listing agreement for Quebec.
Saviuk says winning the province of Quebec is critical to the commercial success of the drug and for patients to have access to the drug without having to pay from their own pockets.